暂无数据
暂无内容
行业更新:医疗保健
周五下午晚些时候,医疗保健股涨跌互现,纽约证券交易所医疗保健指数小幅下跌,医疗保健精选板块SPDR基金(XLV)上涨0.1%。iShares 生物技术 ETF (IB)
Marinus 完成结节性硬化症综合体试验的入组;获得新专利
Marinus Pharmicals(MRNS)周五表示,它已经完成了口服加那索龙的3期试验的入组,该试验用于治疗与儿童结节性硬化综合症相关的癫痫发作
这就是Marinus Pharmicals(MRNS)在4周内下跌-7.8%后有望出现转机的原因
买入评级得到确认:Marinus Pharmaceuticals的进步和长期专利保护预示着强劲的前景
Marinus Pharmicals完成了结节性硬化综合症治疗的3期试验入组,目标是继3期癫痫发作治疗试验后的2025年新药申请
致力于开发治疗癫痫发作障碍的创新疗法的制药公司Marinus Pharmicals, Inc.(纳斯达克股票代码:MRNS)今天宣布完成该项目的注册
快讯 | Marinus Pharmicals Inc:第三阶段 Trusttsc 试验的注册已完成,预计将在 2024 年第四季度上半年公布头条数据
STD0313 : what is up with the huge drop from 10 to 1 dollar......MM making room for themselves? Did they file something late.....took a very quick scan and didn't see anything
Trytosaveabit楼主 STD0313: So this is how I see it! Bad earnings. Hedge funds shorting! Also when you have 50% of the daily volume going off exchange, it keeps a buying pressure of the board that would move price up. Take yesterday! Volume was just over 900K and damn close to 500K of that was routed off exchange! Kinda criminal IMO! There is over 5M shares sold short!